Table 1.

Sensitivity and specificity of pentraxin-3 in lung cancer patients

SpecificitySensitivity
Versus high-risk controls aVersus all controls a
Estimate95% CIEstimate95% CI
0.990.054(0.000–0.158)0.054(0.000–0.133)
0.950.192(0.094–0.296)0.177(0.118–0.281)
0.900.374(0.212–0.478)0.251(0.163–0.399)
0.800.478(0.394–0.557)0.448(0.365–0.542)
0.700.611(0.493–0.734)0.512(0.419–0.611)
0.600.719(0.621–0.783)0.655(0.542–0.734)
0.500.744(0.670–0.798)0.739(0.680–0.808)
  • aPlease see text for descriptions.